Managing Ipo Execution Processes

Managing IPO Execution Processes

When To Use

• Coordinating an IPO from organizational meeting through pricing and allocation
• Tracking parallel workstreams across issuer, underwriters, legal counsel, auditors, and transfer agent
• Building or updating an IPO execution timeline with milestone dependencies
• Preparing status reports for syndicate calls, steering committee meetings, or board updates
• Managing the transition from confidential filing to public marketing

Inputs To Gather

• Deal parameters: Issuer name, proposed exchange listing, estimated offering size, share structure (primary vs. secondary), greenshoe allocation
• Working group list: Lead bookrunners, co-managers, issuer's counsel, underwriters' counsel, auditors, printer/EDGAR agent, transfer agent, D&O insurance broker
• Timeline anchors: Target confidential submission date, anticipated public filing date, launch date, pricing date, closing date
• Regulatory context: SEC review status, exchange listing application status, FINRA filing status, blue sky / state requirements [VERIFY]
• Issuer readiness: Audit status (PCAOB-compliant financials), committee charters and independence requirements, corporate governance documents, executive compensation disclosure readiness

Workflow

Phase 1 — Organization (Weeks 1–3)

1. Conduct organizational meeting; circulate working group list and responsibility matrix
2. Distribute initial timeline with key milestone dates and dependencies
3. Confirm engagement letters for bookrunners, counsel, auditors, and printer
4. Establish virtual data room structure and access protocols
5. Initiate due diligence workstreams: business, financial, legal, IP, tax

Phase 2 — Drafting & Filing (Weeks 3–10)

1. Coordinate S-1/F-1 drafting sessions between issuer counsel and underwriters' counsel
2. Track comfort letter deliverables and audit completion milestones
3. Manage parallel tracks: prospectus drafting, financial statement preparation, legal opinion preparation
4. Submit confidential draft registration statement to SEC via EDGAR
5. File Form 8-A for exchange registration; submit listing application to NYSE/Nasdaq [VERIFY exchange-specific requirements]
6. Prepare and file FINRA corporate financing review package

Phase 3 — SEC Review & Amendment (Weeks 10–16)

1. Track SEC comment letter receipt (typically 25–30 calendar days after initial submission) [VERIFY current review timelines]
2. Coordinate responses across working group; manage amendment drafting schedule
3. Update financial statements if stale date approaches (135-day rule for annual financials; interim stub requirements) [VERIFY staleness rules under S-X]
4. File amendments incorporating SEC comments; track clearance status
5. Confirm FINRA "no objections" letter received before effectiveness

Phase 4 — Marketing & Pricing (Weeks 16–19)

1. Coordinate analyst day / analyst publication timing with research teams (observe 25-day quiet period post-publication for managers, 10 days for non-managers) [VERIFY research blackout rules under FINRA/SEC guidance]
2. Prepare and distribute preliminary prospectus ("red herring") to institutional investors
3. Build roadshow schedule: management presentations, one-on-ones, group lunches, virtual meetings
4. Track daily order book updates from bookrunners; prepare demand summary reports
5. Coordinate pricing call: confirm final offering price, share allocation, greenshoe exercise
6. File final prospectus (424(b)) within two business days of pricing; confirm effectiveness

Phase 5 — Closing (T+3/T+4)

1. Coordinate closing deliverables: legal opinions, comfort letters (bring-down), officer certificates, good standing certificates
2. Confirm DTC eligibility and share delivery mechanics with transfer agent
3. Track closing funds flow and settlement
4. File Form 8-K with closing details; confirm lock-up agreements executed
5. Archive complete transaction record in deal file

Output

Produce an IPO Execution Status Report containing:

• Timeline tracker: Gantt-style milestone view showing completed, in-progress, and upcoming items with responsible parties and target dates
• Workstream status matrix: Each workstream (S-1 drafting, due diligence, SEC review, listing, FINRA, roadshow, closing) with current status, open items, and blockers
• Critical path items: Tasks currently on the critical path with risk flags for any slippage
• Decision log: Key decisions made (pricing range, allocation approach, greenshoe size) with dates and approving parties
• Open issues list: Unresolved items requiring working group attention, ranked by urgency

Quality Checks

• Verify all timeline dates reflect actual working group consensus, not placeholder estimates
• Confirm SEC filing deadlines account for EDGAR filing windows and processing times
• Validate that financial statement staleness dates are calculated correctly under Regulation S-X [VERIFY]
• Ensure lock-up period terms match across underwriting agreement, lock-up agreements, and prospectus disclosure
• Cross-check that FINRA filing fee calculations align with proposed maximum aggregate offering price
• Confirm all working group members have current contact information and role assignments
• Flag any missing deliverables that could block the critical path to pricing or closing